How The Reset Price Target Is Shaping The Emergent BioSolutions (EBS) Investment Story [Yahoo! Finance]
Emergent BioSolutions Inc. (EBS)
Last emergent biosolutions inc. earnings: 4/30 04:08 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.emergentbiosolutions.com
Company Research
Source: Yahoo! Finance
Analysts have reset their price target on Emergent BioSolutions to US$12 from US$15, keeping the fair value estimate at US$12 while reflecting reduced earnings expectations. The new target, described as a cut but still above where the stock is implied to trade after the earnings miss, aligns analyst views more closely with current assumptions while maintaining a positive stance on the company. As you read on, you will see how this updated target fits into the evolving narrative and what it could mean for your own view of the stock. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Emergent BioSolutions. What Wall Street Has Been Saying ?? Bullish Takeaways H.C. Wainwright maintains a Buy rating on Emergent BioSolutions, signaling that, despite recent earnings pressure, the firm still sees upside potential relative to the current share price. The updated US$12 price target is aligned with the fair value estim
Show less
Read more
Impact Snapshot
Event Time:
EBS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EBS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EBS alerts
High impacting Emergent BioSolutions Inc. news events
Weekly update
A roundup of the hottest topics
EBS
News
- Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical CountermeasuresGlobeNewswire
- How The Investment Narrative For Emergent BioSolutions (EBS) Is Shifting After The $12 Target Reset [Yahoo! Finance]Yahoo! Finance
- BioThrax (Emergent BioSolutions) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]Yahoo! Finance
- Acam2000 Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]Yahoo! Finance
- Emergent Biosolutions (EBS) had its price target lowered by HC Wainwright from $15.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
EBS
Earnings
- 10/29/25 - Beat
EBS
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/20/26 - Form ARS
- 3/20/26 - Form DEFA14A
- EBS's page on the SEC website